title: Intracellular supply of phospholipids for biliary secretion: evidence for a nonvesicular transport component.
abstract: Phospholipids (PL) for biliary secretion could be supplied from the endoplasmic reticulum (ER) to the plasma membrane by cytosolic transfer proteins or transport vesicles. Therefore, we studied whether biliary secretions of PL and apolipoprotein A-I (apo A-I), as markers for the ER-to-Golgi vesicular transport pathway, are tightly coupled in isolated perfused rat livers with enhanced secretion (+60%) of PL after withdrawal of the cholesterol synthesis inhibitor pravastatin (0.1% of chow, fed for 7 days). Blocking agents dissociated the secretion of apo A-I and PL. Brefeldin A as well as cycloheximide inhibited biliary secretion of apo A-I (-52%; -68%), however, not of PL. Both bilirubin ditaurate and taurodehydrocholic acid reduced biliary secretion of PL (-27%; -79%), but not of apo A-I. The data support the concept that PL destined for biliary secretion bypass the vesicular transport pathway of apo A-I through the Golgi compartment, most likely via cytosolic transfer proteins.
authors.affiliation: Department of Medicine II, University of Leipzig, Leipzig, D-04103, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Jaeger
authors.forename: H G
authors.initials: HG
authors.lastname: Wilcox
authors.forename: T
authors.initials: T
authors.lastname: Bitterle
authors.forename: J
authors.initials: J
authors.lastname: Mössner
authors.forename: F
authors.initials: F
authors.lastname: Berr
mesh_terms: D000818:Animals; D016632:Apolipoprotein A-I / Q000378:metabolism; D001646:Bile / Q000187:drug effects / Q000378:metabolism*; D001663:Bilirubin / Q000031:analogs & derivatives / Q000494:pharmacology; D001693:Biological Transport, Active; D020126:Brefeldin A / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006056:Golgi Apparatus / Q000378:metabolism; D066298:In Vitro Techniques; D007424:Intracellular Fluid / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010477:Perfusion; D010743:Phospholipids / Q000378:metabolism*; D017035:Pravastatin / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013654:Taurine / Q000031:analogs & derivatives / Q000494:pharmacology; D013656:Taurocholic Acid / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D016632:Apolipoprotein A-I; D002352:Carrier Proteins; D010743:Phospholipids; D013654:Taurine; D020126:Brefeldin A; C019560:taurodehydrocholate; D013656:Taurocholic Acid; C054146:bilirubin ditaurine; D003513:Cycloheximide; D017035:Pravastatin; D001663:Bilirubin